Stocktoria
Fortress Biotech, Inc. FBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-11-17
Fortress Biotech, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Jin David | Chief Financial Officer | 2026-06-22 | Grant | 400,000 | — |
| Jin David | Chief Financial Officer | 2026-04-01 | Grant | 2,967 | $2.18 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | 2026-03-18 | Grant | 475,424 | — |
| WEISS MICHAEL S | Executive Vice Chairman | 2026-03-18 | Grant | 475,424 | — |
| Fortress Biotech, Inc. | 10% owner | 2026-01-02 | Grant | 278,385 | — |
| Fortress Biotech, Inc. | 10% owner | 2026-01-02 | Grant | 111,209 | — |
| Hoenlein Malcolm | director | 2026-01-01 | Grant | 27,322 | — |
| Klein Dov | director | 2026-01-01 | Grant | 27,322 | — |
Source: SEC EDGAR filings · CIK 0001429260 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.